Coexistence of dermatomyositis and macrophagic myofasciitis;Coexistence d'une dermatomyosite et d'une myofasciite à macrophages

Presse Medicale

Volumn 34, Issue 6, 2005, Pages 438-440

  Lazaro, E ^a   Doutre, Marie Sylvie ^a   Coquet, M ^b   Bouillot, S ^b   Beylot Barry, M ^a   Beylot, C ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE PREDISPOSITION; FASCIITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; MACROPHAGE; MACROPHAGIC MYOFASCIITIS; MUSCLE DISEASE;

EID: 16444385648     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)83938-7     Document Type: Article

References (12)

1. Gherardi RK, Coquet M, Cherin P, Authier FJ, Laforêt P, Belec L et al. Macrophagic myofasciitis: an emerging entity. Groupe d'études et recherche sur les maladies musculaires acquises et dysimmunitaires (GERMMAD) de l'Association francaise contre les myopathies (AFM). Lancet 1998; 352: 347-52.
2. Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001; 124: 974-83.
3. Gherardi RK, Authier FJ. Aluminium inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am 2003; 23: 699-712.
4. Figarella-Brander D, Lacroix D, Coquet M, Gherardi R, Pellissier JF. Myopathies inflammatoires idiopathiques. Ann Pathol 2001; 21: 279-84.
5. Civatte M, Schleinitz N, Krammer P, Fernandez C, Guis S, Veit V et al. Class I MHC detection as a diagnostic tool in non informative muscle biopsies of patients suffering from dermatomyositis (DM). Neuropathol Appl Neurobiol 2003; 29: 546-52.
6. Bassez G, Authier FJ, Lechapt-Zalcman E, Delfau-Larue MH, Plonquet A, Coquet M et al. Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis. J Neuropathol Exp Neurol 2003; 62: 454-74.
7. Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA et al. Macrophagic myofasciitis lesions assess long-term persistance of vaccine-derive aluminium hydroxyde in muscle. Brain 2001; 124: 1821-31.
8. Gherardi RK. Myofasciite à macrophages et hydroxyde d'alumine: vers la d́finition d'un syndrome des adjuvants. Rev Neurol (Paris) 2003; 159: 162-4.
9. Cherin P, Laforêt P, Gherardi RK, Authier FJ, Coquet M, Maisonobe T et al. La myofasciite à macrophages: description, hypothèses étiopathogéniques. Rev Med Interne 1999; 20: 483-9.
10. Cherin P, Pelletier S, Laforêt P. Statut immunologique au cours de la myofasciite à macrophages. Rev Med Interne 2001; 22, Suppl 1, 61s.
11. Cherin P, Menard D, Mouton P, Viallard JF, Le Hello C, Authier FJ et al. Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases. Neuromuscul Disord 2001; 11: 452-7.
12. Guis S, Pelissier JF, Nicoli F, Reviron D, Mattei JP, Gherardi RK et al. HLA-DRB101 and macrophagic myofasciitis. Arthritis Rheum 2002; 46: 2535-7.